RPL Peptide

Official Technical Documentation

Application Note

---

Application Note — Retatrutide

Application Note No.: RPL-AN-RET-001 Date: July 2026 Subject: In Vitro Research Protocols for Retatrutide

---

1. cAMP Accumulation Assay

Retatrutide activates GLP-1R, GIPR, and GCGR — all coupled to Gαs — leading to intracellular cAMP accumulation.

Protocol

1. Seed receptor-expressing cells in 384-well plates
2. Add IBMX (0.5 mM) for 15 min
3. Add retatrutide serial dilutions (10⁻¹² to 10⁻⁶ M)
4. Incubate 30 min at 37°C
5. Lyse and measure cAMP per kit instructions
6. Calculate EC₅₀

Expected EC₅₀

• GLP-1R: 0.5–5 nM
• GIPR: 0.1–2 nM
• GCGR: 1–10 nM

2. Beta-Arrestin Recruitment

Use PathHunter or BRET-compatible cells expressing target receptors.

3. Binding Affinity

Radioligand binding assay with [¹²⁵I]-GLP-1, [¹²⁵I]-GIP, or [¹²⁵I]-glucagon.

4. Notes

• Use low-binding tubes
• DMSO ≤0.1% final
• Triplicate, repeat ≥3 times

---

© 2026 RPL Peptide

Official Technical Documentation

rplpeptides.com